1985
DOI: 10.1212/wnl.35.2.235
|View full text |Cite
|
Sign up to set email alerts
|

L‐dopa‐induced respiratory disturbance in Parkinson's disease suppressed by tiapride

Abstract: L-dopa treatment provoked an irregular breathing pattern and dyspnea in a patient with Parkinson's disease. This side effect strongly limited adequate antiparkinsonian treatment with L-dopa. Simultaneous administration of L-dopa and tiapride resulted in improvement of parkinsonian symptoms and suppressed the respiratory side effect completely.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
26
0

Year Published

2002
2002
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(27 citation statements)
references
References 0 publications
0
26
0
Order By: Relevance
“…Symptomatic dyspnea with irregularities of respiratory rate and depth beginning 30 to 120 minutes after L-dopa, coinciding with peak L-dopa effect, has been reported in 6 patients. 1,[10][11][12][13] In 4 of these, respiratory patterns before and after L-dopa administration were characterized by using spirometry or plethysmography. 1,11,12 These respiratory abnormalities appeared after the introduction of L-dopa or an increase in L-dopa dose, and resolved with reduction of L-dopa dose.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Symptomatic dyspnea with irregularities of respiratory rate and depth beginning 30 to 120 minutes after L-dopa, coinciding with peak L-dopa effect, has been reported in 6 patients. 1,[10][11][12][13] In 4 of these, respiratory patterns before and after L-dopa administration were characterized by using spirometry or plethysmography. 1,11,12 These respiratory abnormalities appeared after the introduction of L-dopa or an increase in L-dopa dose, and resolved with reduction of L-dopa dose.…”
Section: Discussionmentioning
confidence: 99%
“…1,[10][11][12][13] In 4 of these, respiratory patterns before and after L-dopa administration were characterized by using spirometry or plethysmography. 1,11,12 These respiratory abnormalities appeared after the introduction of L-dopa or an increase in L-dopa dose, and resolved with reduction of L-dopa dose. In 1 case, administration of the dopamine agonist tiapride suppressed the abnormal respiratory pattern.…”
Section: Discussionmentioning
confidence: 99%
“…Keywords Voluntary cough Á Airflow Á Penetration Á Parkinson's disease Á Deglutition Á Deglutition disorders Symptoms of Parkinson's disease (PD) may include bradykinesia (slowness of movement), resting tremor, rigidity, postural abnormalities [1,2], respiratory difficulty (including dysrhythmias), [1,3], respiratory muscle weakness [1,4], and/or laryngeal muscle abnormalities [1]. Dysphagia (swallowing dysfunction) can occur in the early stages of PD and aspiration pneumonia is reported as the leading cause of death in PD patients [5,6].…”
mentioning
confidence: 99%
“…In Parkinsonian patients, an excessive duration of EMG activity of the inspiratory muscles in the course of the expiration phase [6] and prolongation of the strain period of the diaphragm [7] were observed. Drops in the forced vital capacity (FVC), total lung capacity (TLC), maximum lung ventilation (MLV), forced expiratory volume per 1 sec (FEV 1 ), Tiffno's index (FEV 1 %VC; this shift is combined with an increase in the residual ventilation, RV), and the total resistance of respiratory pathways (R rs ) [3,[8][9][10][11][12][13][14] are indicative of a noticeable restriction of the functional resources of the mechanical respiratory apparatus. At the same time, some experimenters reported that relatively normal indices of VC, FEV 1 %VC [15], and FEV 1 [9] are preserved in a considerable part of the patients; in these cases, obturation of the respiratory pathways corresponded only to a subclinical level.…”
Section: The State Of the Mechanical Apparatus Of Lung Ventilation In Pdmentioning
confidence: 99%